Home
>
National Drug Code (NDC)
>
Zometa
Zometa - 0078-0387-25 - (zoledronic acid)
Drug Information of Zometa
| Product NDC: | 0078-0387 |
| Proprietary Name: | Zometa |
| Non Proprietary Name: | zoledronic acid |
| Active Ingredient(s): | 4 mg/5mL & nbsp; zoledronic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zometa
| Product NDC: | 0078-0387 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021223 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010820 |
Package Information of Zometa
| Package NDC: | 0078-0387-25 |
| Package Description: | 1 VIAL in 1 CARTON (0078-0387-25) > 5 mL in 1 VIAL |
NDC Information of Zometa
| NDC Code | 0078-0387-25 |
| Proprietary Name | Zometa |
| Package Description | 1 VIAL in 1 CARTON (0078-0387-25) > 5 mL in 1 VIAL |
| Product NDC | 0078-0387 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zoledronic acid |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20010820 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ZOLEDRONIC ACID |
| Strength Number | 4 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
